| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $8.5M-66.1% | $25.0M | — | $92.9M-12.4% | $106.1M-47.1% | $200.4M+169.7% | $74.3M+22.4% | $60.7M |
| Short-term investments | $0-100.0% | $17.5M | — | $149.9M-43.4% | $265.0M-11.7% | $300.3M+62.5% | $184.8M-25.8% | $248.9M |
| Restricted cash | $0-100.0% | $146K | — | $146K-24.7% | $194K+0.0% | $194K+0.0% | $194K+0.0% | $194K |
| Accounts receivable | $1.3M-15.5% | $1.5M | — | $40.2M+3979.2% | $986K-21.1% | $1.3M | $0 | — |
| Inventories | $0-100.0% | $10.7M | — | $1.6M | $0 | — | — | — |
| Other current assets | $2.5M-75.5% | $10.1M | — | $10.3M-16.7% | $12.4M | — | — | — |
| Total current assets | $12.2M-81.2% | $64.9M | — | $295.1M-23.3% | $384.6M-26.5% | $523.3M+91.7% | $273.0M-15.1% | $321.5M |
| Property and equipment, net | $73K-94.4% | $1.3M | — | $6.3M-88.3% | $53.8M+6.5% | $50.5M-6.8% | $54.2M-21.0% | $68.6M |
| Operating lease assets | $7.1M-82.3% | $39.8M | — | $68.0M+160.0% | $26.2M+112.6% | $12.3M-12.2% | $14.0M | $0 |
| Other assets | $886K-71.4% | $3.1M | — | $7.0M+196.5% | $2.4M+186.2% | $827K+45.9% | $567K-1.2% | $574K |
| Total assets | $20.2M-81.5% | $109.1M | — | $376.4M-19.6% | $468.1M-20.4% | $588.1M+71.5% | $342.9M-12.5% | $391.8M |
| Accounts payable | $127K-97.1% | $4.4M | — | $6.9M-60.4% | $17.4M+144.0% | $7.1M-10.6% | $8.0M+114.1% | $3.7M |
| Accrued compensation | $1.3M-80.7% | $6.6M | — | $17.7M-29.8% | $25.1M+22.9% | $20.5M+39.1% | $14.7M+38.3% | $10.6M |
| Accrued research and development expenses | $82K-99.0% | $8.0M | — | $25.0M+85.8% | $13.5M-14.9% | $15.8M+89.6% | $8.3M-56.6% | $19.2M |
| Deferred revenue | $716K-99.2% | $95.1M | — | $8.0M-80.4% | $40.8M+21.8% | $33.5M | $0 | — |
| Liability related to the sale of future revenues - current portion | $9.8M+2452.4% | $382K | — | — | — | — | — | — |
| Other current liabilities | $3.0M-85.2% | $20.2M | — | $21.4M+136.2% | $9.1M+49.5% | $6.1M+5.7% | $5.7M-10.6% | $6.4M |
| Total current liabilities | $14.9M-88.9% | $134.6M | — | $78.9M-25.4% | $105.8M+27.6% | $82.9M+125.6% | $36.7M-8.1% | $40.0M |
| Operating lease liabilities - long-term | $9.3M-68.8% | $29.9M | — | $58.1M+127.5% | $25.5M+95.7% | $13.0M-7.7% | $14.1M | $0 |
| Liability related to the sale of future revenues - long-term | $32.7M-15.4% | $38.6M | — | $30.2M | $0 | — | — | — |
| Other long-term liabilities | $1.8M-45.1% | $3.3M | — | $5.6M+270.7% | $1.5M-26.6% | $2.0M+59.4% | $1.3M-90.1% | $13.0M |
| Total liabilities | $58.7M-71.5% | $206.4M | — | $249.8M+32.5% | $188.5M+49.9% | $125.8M+141.1% | $52.2M-1.5% | $53.0M |
| Common stock - $0.0001 par value, 500,000 shares authorized as of December 31, 2025 and 2024, respectively; 7,324 and 5,859 shares issued and outstanding as of December 31, 2025 and 2024, respectively | $1K+0.0% | $1K | — | $10K+11.1% | $9K+12.5% | $8K+33.3% | $6K+20.0% | $5K |
| Additional paid-in capital | $1.98B+1.3% | $1.96B | — | $1.82B+4.4% | $1.74B+10.0% | $1.59B+43.1% | $1.11B+27.9% | $866.5M |
| Accumulated other comprehensive income | $1K-87.5% | $8K | — | -$2.1M-461.7% | -$368K-224.3% | $296K+34.5% | $220K+164.7% | -$340K |
| Accumulated deficit | -$2.02B+1.6% | -$2.05B | — | -$1.69B-15.6% | -$1.46B-30.2% | -$1.12B-37.5% | -$818.0M-55.1% | -$527.3M |
| Total stockholders' equity (deficit) | -$38.5M+60.4% | -$97.3M-198.0% | $99.2M-21.6% | $126.6M-54.7% | $279.6M-39.5% | $462.3M+59.0% | $290.8M-14.2% | $338.9M |
| Total liabilities and stockholders' equity (deficit) | $20.2M-81.5% | $109.1M | — | $376.4M-19.6% | $468.1M-20.4% | $588.1M+71.5% | $342.9M-12.5% | $391.8M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.